Table 1.

Demographic characteristics of FSGS and HIVAN cases and controls

Population GroupCasesnAge of Onset (yr)ControlsnAge at Blood Donation (yr)Total
African AmericansPrimary FSGS21734 ± 14Normal donors38344 ± 8600
African AmericansHIVAN5436 ± 7HIV + hypernormals23744 ± 6291
European AmericansPrimary FSGS16833 ± 17Normal donors31950 ± 9487
Total4399391378
  • This table summarizes numbers and age distribution of the six groups of subjects studied, as mean ± SD. Hypernormal controls are those that have HIV disease for >8 yr and are lacking evidence of CKD (elevated creatinine or proteinuria). FSGS, focal segmental glomerulosclerosis; HIVAN, HIV-associated collapsing glomerulopathy.